Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY
 
Authors :  S. G. Hymowitz, G. P. De Leon
Date :  04 Jan 10  (Deposition) - 09 Mar 10  (Release) - 25 Sep 13  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.19
Chains :  Asym. Unit :  A,B,H,L,X,Y
Biol. Unit 1:  A,B,H,X,Y  (1x)
Biol. Unit 2:  H,L,X,Y  (1x)
Keywords :  Nrr, Fab Fragment, Antibody, Alpha-Beta-Sandwich, Sea Domain, Lnr, Lin12 Notch Cysteine-Rich, Hd Domain, Cell Cycle, Signaling Protein, Activator, Ank Repeat, Cell Membrane, Developmental Protein, Differentiation, Egf-Like Domain, Glycoprotein, Membrane, Metal- Binding, Notch Signaling Pathway, Immune System (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  Y. Wu, C. Cain-Hom, L. Choy, T. J. Hagenbeek, G. P. De Leon, Y. Chen, D. Finkle, R. Venook, X. Wu, J. Ridgway, D. Schahin-Reed, G. J. Dow, A. Shelton, S. Stawicki, R. J. Watts, J. Zhang, R. Choy, P. Howard, L. Kadyk, M. Yan, J. Zha, C. A. Callahan, S. G. Hymowitz, C. W. Siebel
Therapeutic Antibody Targeting Of Individual Notch Receptors.
Nature V. 464 1052 2010
PubMed-ID: 20393564  |  Reference-DOI: 10.1038/NATURE08878

(-) Compounds

Molecule 1 - ANTI-NRR1 FAB FRAGMENT LIGHT CHAIN
    ChainsA, L
    EngineeredYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    Other DetailsSYNTHETIC ANTIBODY GENERATED WITH PHAGE DISPLAY
    SyntheticYES
 
Molecule 2 - ANTI-NRR1 FAB FRAGMENT HEAVY CHAIN
    ChainsB, H
    EngineeredYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    Other DetailsSYNTHETIC ANTIBODY GENERATED WITH PHAGE DISPLAY
    SyntheticYES
 
Molecule 3 - NEUROGENIC LOCUS NOTCH HOMOLOG PROTEIN 1
    ChainsX, Y
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System Taxid562
    Expression System Vector TypePLASMID
    FragmentNEGATIVE REGULATORY REGION (NRR1)
    GeneHUMAN NOTCH 1, NOTCH1, TAN1
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    Other DetailsPROTEIN SELECTED BY PHAGE DISPLAY
    SynonymNOTCH 1, HN1, TRANSLOCATION-ASSOCIATED NOTCH PROTEIN TAN-1, NOTCH 1 EXTRACELLULAR TRUNCATION, NOTCH 1 INTRACELLULAR DOMAIN

 Structural Features

(-) Chains, Units

  123456
Asymmetric Unit ABHLXY
Biological Unit 1 (1x)ABH XY
Biological Unit 2 (1x)  HLXY

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (3, 9)

Asymmetric Unit (3, 9)
No.NameCountTypeFull Name
1CA6Ligand/IonCALCIUM ION
2NAG2Ligand/IonN-ACETYL-D-GLUCOSAMINE
3SO41Ligand/IonSULFATE ION
Biological Unit 1 (2, 3)
No.NameCountTypeFull Name
1CA-1Ligand/IonCALCIUM ION
2NAG2Ligand/IonN-ACETYL-D-GLUCOSAMINE
3SO41Ligand/IonSULFATE ION
Biological Unit 2 (1, 2)
No.NameCountTypeFull Name
1CA-1Ligand/IonCALCIUM ION
2NAG2Ligand/IonN-ACETYL-D-GLUCOSAMINE
3SO4-1Ligand/IonSULFATE ION

(-) Sites  (9, 9)

Asymmetric Unit (9, 9)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREPHE B:27 , THR B:28 , TYR B:32 , GLY X:1447 , SER X:1448 , VAL X:1727BINDING SITE FOR RESIDUE SO4 B 222
2AC2SOFTWAREASP X:1458 , ASN X:1461 , VAL X:1463 , ASP X:1476 , ASP X:1479BINDING SITE FOR RESIDUE CA X 2001
3AC3SOFTWARETYR X:1500 , ASP X:1503 , HIS X:1505 , ASP X:1507 , ASP X:1518 , ASP X:1521BINDING SITE FOR RESIDUE CA X 2002
4AC4SOFTWAREHIS X:1540 , ASP X:1543 , HIS X:1545 , ASP X:1547 , ASP X:1558 , ASP X:1561BINDING SITE FOR RESIDUE CA X 2003
5AC5SOFTWAREHOH X:79 , LYS X:1489 , ASN X:1490 , SER X:1696 , THR X:1698 , ASP X:1699 , NAG X:2005BINDING SITE FOR RESIDUE NAG X 2004
6AC6SOFTWARENAG X:2004BINDING SITE FOR RESIDUE NAG X 2005
7AC7SOFTWAREASN Y:1461 , VAL Y:1463 , SER Y:1465 , ASP Y:1476BINDING SITE FOR RESIDUE CA Y 2001
8AC8SOFTWARETYR Y:1500 , ASP Y:1503 , HIS Y:1505 , ASP Y:1507 , ASP Y:1518 , ASP Y:1521BINDING SITE FOR RESIDUE CA Y 2002
9AC9SOFTWAREHIS Y:1540 , ASP Y:1543 , HIS Y:1545 , ASP Y:1547 , ASP Y:1558 , ASP Y:1561BINDING SITE FOR RESIDUE CA Y 2003

(-) SS Bonds  (26, 26)

Asymmetric Unit
No.Residues
1A:23 -A:88
2A:134 -A:194
3B:22 -B:92
4B:140 -B:196
5H:22 -H:92
6H:140 -H:196
7L:23 -L:88
8L:134 -L:194
9X:1450 -X:1473
10X:1455 -X:1468
11X:1464 -X:1480
12X:1491 -X:1515
13X:1497 -X:1510
14X:1506 -X:1522
15X:1529 -X:1555
16X:1537 -X:1550
17X:1546 -X:1562
18X:1686 -X:1693
19Y:1464 -Y:1480
20Y:1491 -Y:1515
21Y:1497 -Y:1510
22Y:1506 -Y:1522
23Y:1529 -Y:1555
24Y:1537 -Y:1550
25Y:1546 -Y:1562
26Y:1686 -Y:1693

(-) Cis Peptide Bonds  (8, 8)

Asymmetric Unit
No.Residues
1Ser A:7 -Pro A:8
2Tyr A:140 -Pro A:141
3Phe B:146 -Pro B:147
4Glu B:148 -Pro B:149
5Ser L:7 -Pro L:8
6Tyr L:140 -Pro L:141
7Phe H:146 -Pro H:147
8Glu H:148 -Pro H:149

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (2, 4)

Asymmetric Unit (2, 4)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_071961C1496YNOTC1_HUMANDisease (AOS5)587781259X/YC1497Y
2UniProtVAR_046618V1671INOTC1_HUMANPolymorphism2229968X/YV1672I

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (2, 4)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_071961C1496YNOTC1_HUMANDisease (AOS5)587781259X/YC1497Y
2UniProtVAR_046618V1671INOTC1_HUMANPolymorphism2229968X/YV1672I

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (2, 4)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_071961C1496YNOTC1_HUMANDisease (AOS5)587781259X/YC1497Y
2UniProtVAR_046618V1671INOTC1_HUMANPolymorphism2229968X/YV1672I

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (1, 5)

Asymmetric Unit (1, 5)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1LNRPS50258 LNR (Lin-12/Notch) repeat profile.NOTC1_HUMAN1449-1489
1490-1531
 
1532-1571
 
  5X:1450-1490
X:1491-1532
Y:1491-1532
X:1533-1572
Y:1533-1572
Biological Unit 1 (1, 5)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1LNRPS50258 LNR (Lin-12/Notch) repeat profile.NOTC1_HUMAN1449-1489
1490-1531
 
1532-1571
 
  5X:1450-1490
X:1491-1532
Y:1491-1532
X:1533-1572
Y:1533-1572
Biological Unit 2 (1, 5)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1LNRPS50258 LNR (Lin-12/Notch) repeat profile.NOTC1_HUMAN1449-1489
1490-1531
 
1532-1571
 
  5X:1450-1490
X:1491-1532
Y:1491-1532
X:1533-1572
Y:1533-1572

(-) Exons   (4, 8)

Asymmetric Unit (4, 8)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1ENST000002775411ENSE00001247593chr9:139440314-139440178137NOTC1_HUMAN1-21210--
1.2ENST000002775412ENSE00001124718chr9:139438554-13943847679NOTC1_HUMAN21-47270--
1.3aENST000002775413aENSE00001042401chr9:139418431-139418169263NOTC1_HUMAN47-135890--
1.4aENST000002775414aENSE00000985020chr9:139417640-139417302339NOTC1_HUMAN135-2481140--
1.5ENST000002775415ENSE00001378880chr9:139414017-139413895123NOTC1_HUMAN248-289420--
1.6ENST000002775416ENSE00000985022chr9:139413276-139413043234NOTC1_HUMAN289-367790--
1.7ENST000002775417ENSE00000985023chr9:139412744-139412589156NOTC1_HUMAN367-419530--
1.8ENST000002775418ENSE00000985024chr9:139412389-139412204186NOTC1_HUMAN419-481630--
1.9ENST000002775419ENSE00000985025chr9:139411837-139411724114NOTC1_HUMAN481-519390--
1.10ENST0000027754110ENSE00000985026chr9:139410546-139410433114NOTC1_HUMAN519-557390--
1.11ENST0000027754111ENSE00000985027chr9:139410168-139409935234NOTC1_HUMAN557-635790--
1.12ENST0000027754112ENSE00000985028chr9:139409852-139409742111NOTC1_HUMAN635-672380--
1.13ENST0000027754113ENSE00000985029chr9:139409154-139408962193NOTC1_HUMAN672-736650--
1.14ENST0000027754114ENSE00000985030chr9:139407989-139407844146NOTC1_HUMAN736-785500--
1.15ENST0000027754115ENSE00000985031chr9:139407586-139407473114NOTC1_HUMAN785-823390--
1.16ENST0000027754116ENSE00000985032chr9:139405723-139405604120NOTC1_HUMAN823-863410--
1.17ENST0000027754117ENSE00000985033chr9:139405257-139405105153NOTC1_HUMAN863-914520--
1.18ENST0000027754118ENSE00000985034chr9:139404413-139404185229NOTC1_HUMAN914-990770--
1.19ENST0000027754119ENSE00000985035chr9:139403523-139403322202NOTC1_HUMAN990-1057680--
1.20ENST0000027754120ENSE00000985036chr9:139402837-139402684154NOTC1_HUMAN1058-1109520--
1.21ENST0000027754121ENSE00000985037chr9:139402591-139402407185NOTC1_HUMAN1109-1170620--
1.22ENST0000027754122ENSE00000985038chr9:139401889-139401757133NOTC1_HUMAN1171-1215450--
1.23ENST0000027754123ENSE00000985039chr9:139401425-139401168258NOTC1_HUMAN1215-1301870--
1.24ENST0000027754124ENSE00000985040chr9:139401091-139400979113NOTC1_HUMAN1301-1338380--
1.25ENST0000027754125ENSE00000985041chr9:139400333-139399762572NOTC1_HUMAN1339-15291912X:1447-1530 (gaps)
Y:1461-1530 (gaps)
95
70
1.26aENST0000027754126aENSE00000985042chr9:139399556-139399125432NOTC1_HUMAN1529-16731452X:1530-1674 (gaps)
Y:1530-1674 (gaps)
145
145
1.27ENST0000027754127ENSE00001124572chr9:139397782-139397634149NOTC1_HUMAN1673-1723512X:1674-1724 (gaps)
Y:1674-1724
51
51
1.28bENST0000027754128bENSE00000985044chr9:139396940-139396724217NOTC1_HUMAN1723-1795732X:1724-1727
Y:1724-1726
4
3
1.29ENST0000027754129ENSE00000985045chr9:139396540-13939645388NOTC1_HUMAN1795-1824300--
1.30ENST0000027754130ENSE00000985046chr9:139396365-139396200166NOTC1_HUMAN1825-1880560--
1.31ENST0000027754131ENSE00000985047chr9:139395299-139395004296NOTC1_HUMAN1880-1978990--
1.32ENST0000027754132ENSE00000985048chr9:139393711-139393564148NOTC1_HUMAN1979-2028500--
1.33ENST0000027754133ENSE00000985049chr9:139393448-13939335198NOTC1_HUMAN2028-2060330--
1.34ENST0000027754134ENSE00001247584chr9:139392010-1393888963115NOTC1_HUMAN2061-25554950--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:212
                                                                                                                                                                                                                                                     
               SCOP domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------3l95A02 A:109-212 Immunoglobulins                                                                        CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ...eeee..eeee.....eeeeeee.......eeeeee......eeeee...ee.......eeee....eeeeee...hhhhheeeeeee......ee...eeeee.......eeeee..hhhhhhhheeeeeeeeeee....eeeeeee..ee....eeeee.........eeeeeeeeeehhhhhhh.eeeeeeee......eeeeee.. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                3l95 A    1 DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFYTTPSTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG  212
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210  

Chain B from PDB  Type:PROTEIN  Length:220
                                                                                                                                                                                                                                                             
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains 3l95B01 B:1-113 Immunoglobulins                                                                                        3l95B02 B:114-214 Immunoglobulins                                                                     CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeee..eee.....eeeeeeee..hhhhh.eeeeee.....eeeeeeee....eeee.......eeeeee....eeeeee...hhhhheeeeeeee......eeee...eeeee........eeeee..hhhhh...eeeeeeeeeee.....eeee........eee...ee.....eeeeeeeeee.hhhhhh.eeeeeeehhhheeeeeee... Sec.struct. author
                 SAPs(SNPs) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                3l95 B    1 EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWIHWVRQAPGKGLEWVARINPPNRSNQYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARGSGFRWVMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK  214
                                    10        20        30        40        50     |  59        69        79   |||  86        96    || 104       114       124       134       144       154       164       174       184       194       204       214
                                                                                 55A                         82A||               100J|                                                                                                                  
                                                                                                              82B|                100K                                                                                                                  
                                                                                                               82C                                                                                                                                      

Chain H from PDB  Type:PROTEIN  Length:219
                                                                                                                                                                                                                                                            
               SCOP domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains 3l95H01 H:1-113 Immunoglobulins                                                                                        3l95H02 H:114-213 Immunoglobulins                                                                    CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeee..ee......eeeeeeee..hhhhh.eeeeee.....eeeeeee......eee.hhhh...eeeee....eeeeee...hhhhheeeeeee.........ee...eeee.........eeeee..........eeeeeeeeeee.....eeee........eee...ee.....eeeeeeeeee........eeeeeee....eeeeeee.. Sec.struct. author
                 SAPs(SNPs) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                3l95 H    1 EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWIHWVRQAPGKGLEWVARINPPNRSNQYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARGSGFRWVMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP  213
                                    10        20        30        40        50     |  59        69        79   |||  86        96    || 104       114       124       134       144       154       164       174       184       194       204         
                                                                                 55A                         82A||               100J|                                                                                                                 
                                                                                                              82B|                100K                                                                                                                 
                                                                                                               82C                                                                                                                                     

Chain L from PDB  Type:PROTEIN  Length:212
                                                                                                                                                                                                                                                     
               SCOP domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------3l95L02 L:109-212 Immunoglobulins                                                                        CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ...eeee..eeeee....eeeeeee.......eeeeee......eeeee...ee.......eeee....eeeeee........eeeeeee......ee...eeeeee......eeeee..hhhhhhhheeeeeeeeeee.....eeeeee..ee....eeeee.........eeeeeeeeeehhhhh.....eeeee.......ee...... Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                3l95 L    1 DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFYTTPSTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG  212
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210  

Chain X from PDB  Type:PROTEIN  Length:230
 aligned with NOTC1_HUMAN | P46531 from UniProtKB/Swiss-Prot  Length:2555

    Alignment length:292
                                  1444      1454      1464      1474      1484      1494      1504      1514      1524      1534      1544      1554      1564      1574      1584      1594      1604      1614      1624      1634      1644      1654      1664      1674      1684      1694      1704      1714      1724  
         NOTC1_HUMAN   1435 GAGRDIPPPLIEEACELPECQEDAGNKVCSLQCNNHACGWDGGDCSLNFNDPWKNCTQSLQCWKYFSDGHCDSQCNSAGCLFDGFDCQRAEGQCNPLYDQYCKDHFSDGHCDQGCNSAECEWDGLDCAEHVPERLAAGTLVVVVLMPPEQLRNSSFHFLRELSRVLHTNVVFKRDAHGQQMIFPYYGREEELRKHPIKRAAEGWAAPDALLGQVKASLLPGGSEGGRRRRELDPMDVRGSIVYLEIDNRQCVQASSQCFQSATDVAAFLGALASLGSLNIPYKIEAVQSETV 1726
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author hh-----------hhhhhhhhhhh..........hhhhhhhhh.............hhhhhhhhh......hhhhh...hhhhhhh........hhhhhhhhhhh......hhhhh...hhhhhhh............eeeeee..hhhhhhhhhhhhhhhhhhhhh.eeee.........eee...------------------------------------------------....eeeeeeee.....---.....hhhhhhhhhhhhhhh........eeeeeee.. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------Y------------------------------------------------------------------------------------------------------------------------------------------------------------------------------I------------------------------------------------------- SAPs(SNPs)
                    PROSITE --------------LNR  PDB: X:1450-1490 UniProt: 1449-1489 LNR  PDB: X:1491-1532 UniProt: 1490-1531  LNR  PDB: X:1533-1572 UniProt: 1532-1571----------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.25  PDB: X:1447-1530 (gaps) UniProt: 1339-1529 [INCOMPLETE]                             -----------------------------------------------------------------------------------------------------------------------------------------------Exon 1.27  PDB: X:1674-1724 (gaps)                 --- Transcript 1 (1)
           Transcript 1 (2) ----------------------------------------------------------------------------------------------Exon 1.26a  PDB: X:1530-1674 (gaps) UniProt: 1529-1673                                                                                           -------------------------------------------------1.28 Transcript 1 (2)
                3l95 X 1447 GS-----------ACELPECQEDAGNKVCSLQCNNHACGWDGGDCSLNFNDPWKNCTQSLQCWKYFSDGHCDSQCNSAGCLFDGFDCQRAEGQCNPLYDQYCKDHFSDGHCDQGCNSAECEWDGLDCAEHVPERLAAGTLVVVVLMPPEQLRNSSFHFLRELSRVLHTNVVFKRDAHGQQMIFPYYG------------------------------------------------DVRGSIVYLEIDNRQCV---SQCFQSATDVAAFLGALASLGSLNIPYKIEAVQSETV 1727
                             |       -   |  1455      1465      1475      1485      1495      1505      1515      1525      1535      1545      1555      1565      1575      1585      1595      1605      1615      |  -         -         -         -         -     |1675      1685 |   |1695      1705      1715      1725  
                             |        1449                                                                                                                                                                         1622                                             1671            1687   |                                    
                          1448                                                                                                                                                                                                                                                          1691                                    

Chain Y from PDB  Type:PROTEIN  Length:215
 aligned with NOTC1_HUMAN | P46531 from UniProtKB/Swiss-Prot  Length:2555

    Alignment length:266
                                  1469      1479      1489      1499      1509      1519      1529      1539      1549      1559      1569      1579      1589      1599      1609      1619      1629      1639      1649      1659      1669      1679      1689      1699      1709      1719      
         NOTC1_HUMAN   1460 NKVCSLQCNNHACGWDGGDCSLNFNDPWKNCTQSLQCWKYFSDGHCDSQCNSAGCLFDGFDCQRAEGQCNPLYDQYCKDHFSDGHCDQGCNSAECEWDGLDCAEHVPERLAAGTLVVVVLMPPEQLRNSSFHFLRELSRVLHTNVVFKRDAHGQQMIFPYYGREEELRKHPIKRAAEGWAAPDALLGQVKASLLPGGSEGGRRRRELDPMDVRGSIVYLEIDNRQCVQASSQCFQSATDVAAFLGALASLGSLNIPYKIEAVQSET 1725
               SCOP domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
           Pfam domains (1) ------------------------------------------------------------------Notch-3l95Y05 Y:1527-1563            ---NOD-3l95Y03 Y:1567-1622                                 ------------------------------------------------NODP-3l95Y01 Y:1671-1726                                 Pfam domains (1)
           Pfam domains (2) ------------------------------------------------------------------Notch-3l95Y06 Y:1527-1563            ---NOD-3l95Y04 Y:1567-1622                                 ------------------------------------------------NODP-3l95Y02 Y:1671-1726                                 Pfam domains (2)
           Pfam domains (3) ------------------------------------------------------------------Notch-3l95Y07 Y:1527-1563            ------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains (3)
           Pfam domains (4) ------------------------------------------------------------------Notch-3l95Y08 Y:1527-1563            ------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains (4)
           Pfam domains (5) ------------------------------------------------------------------Notch-3l95Y09 Y:1527-1563            ------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains (5)
           Pfam domains (6) ------------------------------------------------------------------Notch-3l95Y10 Y:1527-1563            ------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains (6)
         Sec.struct. author .........hhhhhhhhh.............hhhhhhhhh......hhhhh...hhhhhhh..---......hhhhhhhh......hhhhhhhhhhhhhhh............eeeeee..hhhhhhhhhhhhhhhhhhhhh.eeee.........eee...------------------------------------------------....eeeeeeee..hhhhhh.....hhhhhhhhhhhhhhh........eeeeeee. Sec.struct. author
                 SAPs(SNPs) ------------------------------------Y------------------------------------------------------------------------------------------------------------------------------------------------------------------------------I------------------------------------------------------ SAPs(SNPs)
                    PROSITE LNR  PDB: - UniProt: 1449-1489LNR  PDB: Y:1491-1532 UniProt: 1490-1531  LNR  PDB: Y:1533-1572 UniProt: 1532-1571---------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.25  PDB: Y:1461-1530 (gaps) UniProt: 1339-1529 [INCOMPLETE]    -----------------------------------------------------------------------------------------------------------------------------------------------Exon 1.27  PDB: Y:1674-1724 UniProt: 1673-1723     -- Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------------------------Exon 1.26a  PDB: Y:1530-1674 (gaps) UniProt: 1529-1673                                                                                           -------------------------------------------------1.2 Transcript 1 (2)
                3l95 Y 1461 NKVCSLQCNNHACGWDGGDCSLNFNDPWKNCTQSLQCWKYFSDGHCDSQCNSAGCLFDGFDCQ---GQCNPLYDQYCKDHFSDGHCDQGCNSAECEWDGLDCAEHVPERLAAGTLVVVVLMPPEQLRNSSFHFLRELSRVLHTNVVFKRDAHGQQMIFPYYG------------------------------------------------DVRGSIVYLEIDNRQCVQASSQCFQSATDVAAFLGALASLGSLNIPYKIEAVQSET 1726
                                  1470      1480      1490      1500      1510      1520  |   1530      1540      1550      1560      1570      1580      1590      1600      1610      1620 |       -         -         -         -         -|     1680      1690      1700      1710      1720      
                                                                                       1523   |                                                                                           1622                                             1671                                                       
                                                                                           1527                                                                                                                                                                                                       

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (0, 0)

(no "SCOP Domain" information available for 3L95)

(-) CATH Domains  (1, 6)

Asymmetric Unit
(-)
Class: Mainly Beta (13760)
1a3l95A02A:109-212
1b3l95B02B:114-214
1c3l95H02H:114-213
1d3l95B01B:1-113
1e3l95H01H:1-113
1f3l95L02L:109-212

(-) Pfam Domains  (3, 10)

Asymmetric Unit
(-)
Family: NODP (2)
1aNODP-3l95Y01Y:1671-1726
1bNODP-3l95Y02Y:1671-1726
(-)
Family: NOD (2)
2aNOD-3l95Y03Y:1567-1622
2bNOD-3l95Y04Y:1567-1622
3aNotch-3l95Y05Y:1527-1563
3bNotch-3l95Y06Y:1527-1563
3cNotch-3l95Y07Y:1527-1563
3dNotch-3l95Y08Y:1527-1563
3eNotch-3l95Y09Y:1527-1563
3fNotch-3l95Y10Y:1527-1563

(-) Gene Ontology  (191, 191)

Asymmetric Unit(hide GO term definitions)
Chain X,Y   (NOTC1_HUMAN | P46531)
molecular function
    GO:0005112    Notch binding    Interacting selectively and non-covalently with the Notch (N) protein, a surface receptor.
    GO:0005509    calcium ion binding    Interacting selectively and non-covalently with calcium ions (Ca2+).
    GO:0031490    chromatin DNA binding    Interacting selectively and non-covalently with DNA that is assembled into chromatin.
    GO:0003682    chromatin binding    Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
    GO:0001047    core promoter binding    Interacting selectively and non-covalently with the regulatory region composed of the transcription start site and binding sites for the basal transcription machinery. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
    GO:0019899    enzyme binding    Interacting selectively and non-covalently with any enzyme.
    GO:0004857    enzyme inhibitor activity    Binds to and stops, prevents or reduces the activity of an enzyme.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0046982    protein heterodimerization activity    Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
    GO:0004872    receptor activity    Combining with an extracellular or intracellular messenger to initiate a change in cell activity.
    GO:0043565    sequence-specific DNA binding    Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
    GO:0003700    transcription factor activity, sequence-specific DNA binding    Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.
    GO:0001190    transcriptional activator activity, RNA polymerase II transcription factor binding    Interacting selectively and non-covalently with an RNA polymerase II transcription factor, which may be a single protein or a complex, in order to increase the frequency, rate or extent of transcription from an RNA polymerase II promoter. A protein binding transcription factor may or may not also interact with the template nucleic acid (either DNA or RNA) as well.
biological process
    GO:0061314    Notch signaling involved in heart development    The series of molecular signals initiated by binding of an extracellular ligand to a Notch receptor on the surface of the target cell and contributing to the progression of the heart over time.
    GO:0007219    Notch signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to the receptor Notch on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0003270    Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation    The series of molecular signals initiated by binding of an extracellular ligand to a Notch receptor on the surface of the target cell contributing to the modulation of the frequency, rate or extent of cardioblast proliferation in the secondary heart field. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0031100    animal organ regeneration    The regrowth of a lost or destroyed animal organ.
    GO:0003180    aortic valve morphogenesis    The process in which the structure of the aortic valve is generated and organized.
    GO:1902263    apoptotic process involved in embryonic digit morphogenesis    Any apoptotic process that is involved in embryonic digit morphogenesis.
    GO:0060842    arterial endothelial cell differentiation    The process in which a relatively unspecialized endothelial cell acquires specialized features of an arterial endothelial cell, a thin flattened cell that lines the inside surfaces of arteries.
    GO:0048708    astrocyte differentiation    The process in which a relatively unspecialized cell acquires the specialized features of an astrocyte. An astrocyte is the most abundant type of glial cell. Astrocytes provide support for neurons and regulate the environment in which they function.
    GO:0003162    atrioventricular node development    The process whose specific outcome is the progression of the atrioventricular (AV) node over time, from its formation to the mature structure. The AV node is part of the cardiac conduction system that controls the timing of ventricle contraction by receiving electrical signals from the sinoatrial (SA) node and relaying them to the His-Purkinje system.
    GO:0003181    atrioventricular valve morphogenesis    The process in which the structure of the atrioventricular valve is generated and organized.
    GO:0009912    auditory receptor cell fate commitment    The process in which the cellular identity of auditory hair cells is acquired and determined.
    GO:0007409    axonogenesis    De novo generation of a long process of a neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells. Refers to the morphogenesis or creation of shape or form of the developing axon.
    GO:0007420    brain development    The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
    GO:0048754    branching morphogenesis of an epithelial tube    The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
    GO:0003209    cardiac atrium morphogenesis    The process in which the cardiac atrium is generated and organized. A cardiac atrium receives blood from a vein and pumps it to a cardiac ventricle.
    GO:0003207    cardiac chamber formation    The developmental process pertaining to the initial formation of a cardiac chamber from unspecified parts. A cardiac chamber is an enclosed cavity within the heart.
    GO:0060317    cardiac epithelial to mesenchymal transition    A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
    GO:0003214    cardiac left ventricle morphogenesis    The process in which the left cardiac ventricle is generated and organized.
    GO:0060038    cardiac muscle cell proliferation    The expansion of a cardiac muscle cell population by cell division.
    GO:0055008    cardiac muscle tissue morphogenesis    The process in which the anatomical structures of cardiac muscle tissue are generated and organized.
    GO:0003213    cardiac right atrium morphogenesis    The process in which the right cardiac atrium is generated and organized.
    GO:0003219    cardiac right ventricle formation    The developmental process pertaining to the initial formation of a right cardiac ventricle from unspecified parts.
    GO:0060411    cardiac septum morphogenesis    The process in which the anatomical structure of a cardiac septum is generated and organized. A cardiac septum is a partition that separates parts of the heart.
    GO:0060948    cardiac vascular smooth muscle cell development    The process whose specific outcome is the progression of a cardiac vascular smooth muscle cell over time, from its formation to the mature state.
    GO:0003208    cardiac ventricle morphogenesis    The process in which the cardiac ventricle is generated and organized. A cardiac ventricle receives blood from a cardiac atrium and pumps it out of the heart.
    GO:0030154    cell differentiation    The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
    GO:0021515    cell differentiation in spinal cord    The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the cells of the spinal cord. Differentiation includes the processes involved in commitment of a cell to a specific fate.
    GO:0045165    cell fate commitment    The commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.
    GO:0001708    cell fate specification    The process involved in the specification of cell identity. Once specification has taken place, a cell will be committed to differentiate down a specific pathway if left in its normal environment.
    GO:0003273    cell migration involved in endocardial cushion formation    The orderly movement of a cell from one site to another that will contribute to the formation of an endocardial cushion. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
    GO:0071372    cellular response to follicle-stimulating hormone stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus.
    GO:0035924    cellular response to vascular endothelial growth factor stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
    GO:0060271    cilium assembly    The assembly of a cilium, a specialized eukaryotic organelle that consists of a filiform extrusion of the cell surface. Each cilium is bounded by an extrusion of the cytoplasmic membrane, and contains a regular longitudinal array of microtubules, anchored basally in a centriole.
    GO:0072044    collecting duct development    The process whose specific outcome is the progression of a collecting duct over time, from its formation to the mature structure. The collecting duct responds to vasopressin and aldosterone to regulate water, electrolyte and acid-base balance. It is the final common path through which urine flows before entering the ureter and then emptying into the bladder.
    GO:0007386    compartment pattern specification    The regionalization process in which embryonic segments are divided into compartments that will result in differences in cell differentiation.
    GO:0060982    coronary artery morphogenesis    The process in which the anatomical structures of coronary arteries are generated and organized. Coronary arteries are blood vessels that transport blood to the heart muscle.
    GO:0003169    coronary vein morphogenesis    The process in which the anatomical structures of veins of the heart are generated and organized.
    GO:0007368    determination of left/right symmetry    The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
    GO:0072017    distal tubule development    The process whose specific outcome is the progression of the distal tubule over time, from its formation to the mature structure. In mammals, the distal tubule is a nephron tubule that begins at the macula densa and extends to the connecting tubule.
    GO:0035116    embryonic hindlimb morphogenesis    The process, occurring in the embryo, by which the anatomical structures of the hindlimbs are generated and organized. The hindlimbs are the posterior limbs of an animal.
    GO:0030326    embryonic limb morphogenesis    The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
    GO:0060956    endocardial cell differentiation    The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of an endocardial cell. An endocardial cell is a specialized endothelial cell that makes up the endocardium portion of the heart. The endocardium is the innermost layer of tissue of the heart, and lines the heart chambers.
    GO:0003197    endocardial cushion development    The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
    GO:0003203    endocardial cushion morphogenesis    The process in which the anatomical structure of the endocardial cushion is generated and organized. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
    GO:0003157    endocardium development    The process whose specific outcome is the progression of the endocardium over time, from its formation to the mature structure. The endocardium is an anatomical structure comprised of an endothelium and an extracellular matrix that forms the innermost layer of tissue of the heart, and lines the heart chambers.
    GO:0003160    endocardium morphogenesis    The process in which the anatomical structure of the endocardium is generated and organized. The endocardium is an anatomical structure comprised of an endothelium and an extracellular matrix that forms the innermost layer of tissue of the heart, and lines the heart chambers.
    GO:0007492    endoderm development    The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.
    GO:0008544    epidermis development    The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.
    GO:0001837    epithelial to mesenchymal transition    A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
    GO:0003198    epithelial to mesenchymal transition involved in endocardial cushion formation    A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell that will contribute to the formation of the endocardial cushion.
    GO:0030900    forebrain development    The process whose specific outcome is the progression of the forebrain over time, from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).
    GO:0007440    foregut morphogenesis    The process in which the anatomical structures of the foregut are generated and organized.
    GO:0010001    glial cell differentiation    The process in which a relatively unspecialized cell acquires the specialized features of a glial cell.
    GO:0072144    glomerular mesangial cell development    The process whose specific outcome is the progression of a glomerular mesangial cell in the kidney over time, from its formation to the mature structure.
    GO:0003241    growth involved in heart morphogenesis    Developmental growth that contributes to the shaping of the heart.
    GO:0031069    hair follicle morphogenesis    The process in which the anatomical structures of the hair follicle are generated and organized.
    GO:0007507    heart development    The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
    GO:0001947    heart looping    The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
    GO:0061384    heart trabecula morphogenesis    The process of shaping a trabecula in the heart. A trabecula is a small, often microscopic, tissue element in the form of a small beam, strut or rod, which generally has a mechanical function. Trabecula are usually but not necessarily, composed of dense collagenous tissue.
    GO:0006959    humoral immune response    An immune response mediated through a body fluid.
    GO:0006955    immune response    Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
    GO:0001701    in utero embryonic development    The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
    GO:0002437    inflammatory response to antigenic stimulus    An inflammatory response to an antigenic stimulus, which can be include any number of T cell or B cell epitopes.
    GO:0072602    interleukin-4 secretion    The regulated release of interleukin-4 from a cell.
    GO:0030216    keratinocyte differentiation    The process in which a relatively unspecialized cell acquires specialized features of a keratinocyte.
    GO:0070986    left/right axis specification    The establishment, maintenance and elaboration of the left/right axis. The left/right axis is defined by a line that runs orthogonal to both the anterior/posterior and dorsal/ventral axes. Each side is defined from the viewpoint of the organism rather of the observer (as per anatomical axes).
    GO:0001889    liver development    The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.
    GO:0030324    lung development    The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
    GO:0014031    mesenchymal cell development    The process aimed at the progression of a mesenchymal cell over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell.
    GO:0003192    mitral valve formation    The developmental process pertaining to the initial formation of the mitral valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0030514    negative regulation of BMP signaling pathway    Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway.
    GO:2000811    negative regulation of anoikis    Any process that stops, prevents or reduces the frequency, rate or extent of anoikis.
    GO:0045608    negative regulation of auditory receptor cell differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of auditory hair cell differentiation.
    GO:0045955    negative regulation of calcium ion-dependent exocytosis    Any process that stops, prevents, or reduces the frequency, rate or extent of calcium ion-dependent exocytosis.
    GO:0090090    negative regulation of canonical Wnt signaling pathway    Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
    GO:0043086    negative regulation of catalytic activity    Any process that stops or reduces the activity of an enzyme.
    GO:0060548    negative regulation of cell death    Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
    GO:0045596    negative regulation of cell differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of cell differentiation.
    GO:0090051    negative regulation of cell migration involved in sprouting angiogenesis    Any process that decreases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
    GO:0008285    negative regulation of cell proliferation    Any process that stops, prevents or reduces the rate or extent of cell proliferation.
    GO:0010812    negative regulation of cell-substrate adhesion    Any process that decreases the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.
    GO:2001027    negative regulation of endothelial cell chemotaxis    Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell chemotaxis.
    GO:0060253    negative regulation of glial cell proliferation    Any process that stops or decreases the rate or extent of glial cell proliferation.
    GO:0045662    negative regulation of myoblast differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
    GO:0010832    negative regulation of myotube differentiation    Any process that decreases the frequency, rate or extent of myotube differentiation. Myotube differentiation is the process in which a relatively unspecialized cell acquires specialized features of a myotube cell. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
    GO:0050768    negative regulation of neurogenesis    Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the origin and formation of neurons.
    GO:0045665    negative regulation of neuron differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of neuron differentiation.
    GO:0048715    negative regulation of oligodendrocyte differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of oligodendrocyte differentiation.
    GO:0030279    negative regulation of ossification    Any process that stops, prevents, or reduces the frequency, rate or extent of bone formation.
    GO:0045668    negative regulation of osteoblast differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation.
    GO:0046533    negative regulation of photoreceptor cell differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of photoreceptor cell differentiation. An example of this process is found in Drosophila melanogaster.
    GO:2000974    negative regulation of pro-B cell differentiation    Any process that stops, prevents or reduces the frequency, rate or extent of pro-B cell differentiation.
    GO:2000737    negative regulation of stem cell differentiation    Any process that stops, prevents or reduces the frequency, rate or extent of stem cell differentiation.
    GO:0000122    negative regulation of transcription from RNA polymerase II promoter    Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0045892    negative regulation of transcription, DNA-templated    Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0021915    neural tube development    The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
    GO:0030182    neuron differentiation    The process in which a relatively unspecialized cell acquires specialized features of a neuron.
    GO:0048663    neuron fate commitment    The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron.
    GO:0097150    neuronal stem cell population maintenance    Any process in by an organism or tissue maintains a population of neuronal stem cells.
    GO:0048709    oligodendrocyte differentiation    The process in which a relatively unspecialized cell acquires the specialized features of an oligodendrocyte. An oligodendrocyte is a type of glial cell involved in myelinating the axons of neurons in the central nervous system.
    GO:0003344    pericardium morphogenesis    The process in which the anatomical structure of the pericardium is generated and organized.
    GO:0030513    positive regulation of BMP signaling pathway    Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
    GO:0046427    positive regulation of JAK-STAT cascade    Any process that activates or increases the frequency, rate or extent of the JAK-STAT signaling pathway activity.
    GO:0045747    positive regulation of Notch signaling pathway    Any process that activates or increases the frequency, rate or extent of the Notch signaling pathway.
    GO:0043065    positive regulation of apoptotic process    Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
    GO:0048711    positive regulation of astrocyte differentiation    Any process that activates or increases the frequency, rate or extent of astrocyte differentiation.
    GO:0060045    positive regulation of cardiac muscle cell proliferation    Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0045603    positive regulation of endothelial cell differentiation    Any process that activates or increases the frequency, rate or extent of endothelial cell differentiation.
    GO:0050679    positive regulation of epithelial cell proliferation    Any process that activates or increases the rate or extent of epithelial cell proliferation.
    GO:0010718    positive regulation of epithelial to mesenchymal transition    Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
    GO:0045687    positive regulation of glial cell differentiation    Any process that activates or increases the frequency, rate or extent of glia cell differentiation.
    GO:0045618    positive regulation of keratinocyte differentiation    Any process that activates or increases the frequency, rate or extent of keratinocyte differentiation.
    GO:0002052    positive regulation of neuroblast proliferation    Any process that activates or increases the rate of neuroblast proliferation.
    GO:0045944    positive regulation of transcription from RNA polymerase II promoter    Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0061419    positive regulation of transcription from RNA polymerase II promoter in response to hypoxia    Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
    GO:0007221    positive regulation of transcription of Notch receptor target    The activation of transcription of specific genes as a result of Notch signaling, mediated by the Notch intracellular domain.
    GO:0045893    positive regulation of transcription, DNA-templated    Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0045070    positive regulation of viral genome replication    Any process that activates or increases the frequency, rate or extent of viral genome replication.
    GO:0050434    positive regulation of viral transcription    Any process that activates or increases the frequency, rate or extent of viral transcription.
    GO:0060740    prostate gland epithelium morphogenesis    The process in which the anatomical structures of epithelia of the prostate gland are generated and organized. An epithelium consists of closely packed cells arranged in one or more layers, that covers the outer surfaces of the body or lines any internal cavity or tube.
    GO:0003184    pulmonary valve morphogenesis    The process in which the structure of the pulmonary valve is generated and organized.
    GO:0008593    regulation of Notch signaling pathway    Any process that modulates the frequency, rate or extent of the Notch signaling pathway.
    GO:0045607    regulation of auditory receptor cell differentiation    Any process that modulates the frequency, rate or extent of auditory hair cell differentiation.
    GO:0003264    regulation of cardioblast proliferation    Any process that modulates the frequency, rate or extent of cardioblast proliferation. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
    GO:0030334    regulation of cell migration    Any process that modulates the frequency, rate or extent of cell migration.
    GO:0042127    regulation of cell proliferation    Any process that modulates the frequency, rate or extent of cell proliferation.
    GO:0050793    regulation of developmental process    Any process that modulates the frequency, rate or extent of development, the biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote, or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0050678    regulation of epithelial cell proliferation    Any process that modulates the frequency, rate or extent of epithelial cell proliferation.
    GO:0060768    regulation of epithelial cell proliferation involved in prostate gland development    Any process that modulates the rate, frequency or extent of epithelial cell proliferation that contributes to the progression of the prostate gland over time.
    GO:1901201    regulation of extracellular matrix assembly    Any process that modulates the frequency, rate or extent of extracellular matrix assembly.
    GO:0010468    regulation of gene expression    Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0050767    regulation of neurogenesis    Any process that modulates the frequency, rate or extent of neurogenesis, the origin and formation of neurons.
    GO:0014807    regulation of somitogenesis    Any process that modulates the frequency, rate or extent of somitogenesis.
    GO:0006357    regulation of transcription from RNA polymerase II promoter    Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0003256    regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation    Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter that contributes to the differentiation of a myocardial precursor cell.
    GO:0006355    regulation of transcription, DNA-templated    Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0031960    response to corticosteroid    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosteroid hormone stimulus. A corticosteroid is a steroid hormone that is produced in the adrenal cortex. Corticosteroids are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. They include glucocorticoids and mineralocorticoids.
    GO:0032496    response to lipopolysaccharide    Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
    GO:0032495    response to muramyl dipeptide    Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muramyl dipeptide stimulus. Muramyl dipeptide is derived from peptidoglycan.
    GO:0060528    secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development    The process in which a relatively unspecialized epithelial cell acquires specialized features of a secretory columnal luminar epithelial cell of the prostate.
    GO:0035914    skeletal muscle cell differentiation    The process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle.
    GO:0048103    somatic stem cell division    The self-renewing division of a somatic stem cell, a stem cell that can give rise to cell types of the body other than those of the germ-line.
    GO:0007283    spermatogenesis    The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
    GO:0002040    sprouting angiogenesis    The extension of new blood vessels from existing capillaries into avascular tissues resulting from the proliferation of blood vessel endothelial cells.
    GO:0042246    tissue regeneration    The regrowth of lost or destroyed tissues.
    GO:0006366    transcription from RNA polymerase II promoter    The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
    GO:0006367    transcription initiation from RNA polymerase II promoter    Any process involved in the assembly of the RNA polymerase II preinitiation complex (PIC) at an RNA polymerase II promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription.
    GO:0006351    transcription, DNA-templated    The cellular synthesis of RNA on a template of DNA.
    GO:0035148    tube formation    Creation of the central hole of a tube in an anatomical structure through which gases and/or liquids flow.
    GO:0060979    vasculogenesis involved in coronary vascular morphogenesis    The differentiation of endothelial cells from progenitor cells that contributes to blood vessel development in the heart, and the de novo formation of blood vessels and tubes.
    GO:0060843    venous endothelial cell differentiation    The process in which a relatively unspecialized endothelial cell acquires specialized features of a venous endothelial cell, a thin flattened cell that lines the inside surfaces of veins.
    GO:0060412    ventricular septum morphogenesis    The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another.
    GO:0003222    ventricular trabecula myocardium morphogenesis    The process in which the anatomical structures of the trabecular cardiac ventricle muscle are generated and organized.
cellular component
    GO:0005794    Golgi apparatus    A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
    GO:0000139    Golgi membrane    The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
    GO:0002193    MAML1-RBP-Jkappa- ICN1 complex    A protein complex that consists of the intracellular domain of Notch1 (ICN1), the DNA-binding transcription factor RBP-Jkappa, and the transcriptional coactivator Mastermind-like-1 (MAML1); the complex is involved in transcriptional activation in response to Notch-mediated signaling.
    GO:0001669    acrosomal vesicle    A structure in the head of a spermatozoon that contains acid hydrolases, and is concerned with the breakdown of the outer membrane of the ovum during fertilization. It lies just beneath the plasma membrane and is derived from the lysosome.
    GO:0005912    adherens junction    A cell junction at which anchoring proteins (cadherins or integrins) extend through the plasma membrane and are attached to actin filaments.
    GO:0016324    apical plasma membrane    The region of the plasma membrane located at the apical end of the cell.
    GO:0071944    cell periphery    The part of a cell encompassing the cell cortex, the plasma membrane, and any external encapsulating structures.
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0031410    cytoplasmic vesicle    A vesicle found in the cytoplasm of a cell.
    GO:0005829    cytosol    The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
    GO:0005783    endoplasmic reticulum    The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
    GO:0005789    endoplasmic reticulum membrane    The lipid bilayer surrounding the endoplasmic reticulum.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005654    nucleoplasm    That part of the nuclear content other than the chromosomes or the nucleolus.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0043235    receptor complex    Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    CA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    SO4  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Glu B:148 - Pro B:149   [ RasMol ]  
    Glu H:148 - Pro H:149   [ RasMol ]  
    Phe B:146 - Pro B:147   [ RasMol ]  
    Phe H:146 - Pro H:147   [ RasMol ]  
    Ser A:7 - Pro A:8   [ RasMol ]  
    Ser L:7 - Pro L:8   [ RasMol ]  
    Tyr A:140 - Pro A:141   [ RasMol ]  
    Tyr L:140 - Pro L:141   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  3l95
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  NOTC1_HUMAN | P46531
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  616028
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  NOTC1_HUMAN | P46531
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        NOTC1_HUMAN | P465311pb5 1toz 1yyh 2f8x 2f8y 2he0 2vj3 3eto 3i08 3nbn 3v79 4cud 4cue 4cuf 4d0e 4d0f 5fm9 5fma 5kzo

(-) Related Entries Specified in the PDB File

2oo4 STRUCTURE OF LNR-HD (NEGATIVE REGULATORY REGION) FROM HUMAN NOTCH2
3eto CRYSTAL STRUCTURE OF THE S1-CLEAVED NOTCH1 NEGATIVE REGULATORY REGION (NRR)